Cargando…

Control of aging by the renin–angiotensin system: a review of C. elegans, Drosophila, and mammals

The free-living, non-parasitic nematode Caenorhabditis elegans is a premier model organism for the study of aging and longevity due to its short lifespan, powerful genetic tools, and conservation of fundamental mechanisms with mammals. Approximately 70 percent of human genes have homologs in C. eleg...

Descripción completa

Detalles Bibliográficos
Autores principales: Egan, Brian M., Scharf, Andrea, Pohl, Franziska, Kornfeld, Kerry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518657/
https://www.ncbi.nlm.nih.gov/pubmed/36188619
http://dx.doi.org/10.3389/fphar.2022.938650
_version_ 1784799236872732672
author Egan, Brian M.
Scharf, Andrea
Pohl, Franziska
Kornfeld, Kerry
author_facet Egan, Brian M.
Scharf, Andrea
Pohl, Franziska
Kornfeld, Kerry
author_sort Egan, Brian M.
collection PubMed
description The free-living, non-parasitic nematode Caenorhabditis elegans is a premier model organism for the study of aging and longevity due to its short lifespan, powerful genetic tools, and conservation of fundamental mechanisms with mammals. Approximately 70 percent of human genes have homologs in C. elegans, including many that encode proteins in pathways that influence aging. Numerous genetic pathways have been identified in C. elegans that affect lifespan, including the dietary restriction pathway, the insulin/insulin-like growth factor (IGF) signaling pathway, and the disruption of components of the mitochondrial electron transport chain. C. elegans is also a powerful system for performing drug screens, and many lifespan-extending compounds have been reported; notably, several FDA-approved medications extend the lifespan in C. elegans, raising the possibility that they can also extend the lifespan in humans. The renin–angiotensin system (RAS) in mammals is an endocrine system that regulates blood pressure and a paracrine system that acts in a wide range of tissues to control physiological processes; it is a popular target for drugs that reduce blood pressure, including angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). Emerging evidence indicates that this system influences aging. In C. elegans, decreasing the activity of the ACE homolog acn-1 or treatment with the ACE-inhibitor Captopril significantly extends the lifespan. In Drosophila, treatment with ACE inhibitors extends the lifespan. In rodents, manipulating the RAS with genetic or pharmacological interventions can extend the lifespan. In humans, polymorphisms in the ACE gene are associated with extreme longevity. These results suggest the RAS plays a conserved role in controlling longevity. Here, we review studies of the RAS and aging, emphasizing the potential of C. elegans as a model for understanding the mechanism of lifespan control.
format Online
Article
Text
id pubmed-9518657
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95186572022-09-29 Control of aging by the renin–angiotensin system: a review of C. elegans, Drosophila, and mammals Egan, Brian M. Scharf, Andrea Pohl, Franziska Kornfeld, Kerry Front Pharmacol Pharmacology The free-living, non-parasitic nematode Caenorhabditis elegans is a premier model organism for the study of aging and longevity due to its short lifespan, powerful genetic tools, and conservation of fundamental mechanisms with mammals. Approximately 70 percent of human genes have homologs in C. elegans, including many that encode proteins in pathways that influence aging. Numerous genetic pathways have been identified in C. elegans that affect lifespan, including the dietary restriction pathway, the insulin/insulin-like growth factor (IGF) signaling pathway, and the disruption of components of the mitochondrial electron transport chain. C. elegans is also a powerful system for performing drug screens, and many lifespan-extending compounds have been reported; notably, several FDA-approved medications extend the lifespan in C. elegans, raising the possibility that they can also extend the lifespan in humans. The renin–angiotensin system (RAS) in mammals is an endocrine system that regulates blood pressure and a paracrine system that acts in a wide range of tissues to control physiological processes; it is a popular target for drugs that reduce blood pressure, including angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). Emerging evidence indicates that this system influences aging. In C. elegans, decreasing the activity of the ACE homolog acn-1 or treatment with the ACE-inhibitor Captopril significantly extends the lifespan. In Drosophila, treatment with ACE inhibitors extends the lifespan. In rodents, manipulating the RAS with genetic or pharmacological interventions can extend the lifespan. In humans, polymorphisms in the ACE gene are associated with extreme longevity. These results suggest the RAS plays a conserved role in controlling longevity. Here, we review studies of the RAS and aging, emphasizing the potential of C. elegans as a model for understanding the mechanism of lifespan control. Frontiers Media S.A. 2022-09-14 /pmc/articles/PMC9518657/ /pubmed/36188619 http://dx.doi.org/10.3389/fphar.2022.938650 Text en Copyright © 2022 Egan, Scharf, Pohl and Kornfeld. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Egan, Brian M.
Scharf, Andrea
Pohl, Franziska
Kornfeld, Kerry
Control of aging by the renin–angiotensin system: a review of C. elegans, Drosophila, and mammals
title Control of aging by the renin–angiotensin system: a review of C. elegans, Drosophila, and mammals
title_full Control of aging by the renin–angiotensin system: a review of C. elegans, Drosophila, and mammals
title_fullStr Control of aging by the renin–angiotensin system: a review of C. elegans, Drosophila, and mammals
title_full_unstemmed Control of aging by the renin–angiotensin system: a review of C. elegans, Drosophila, and mammals
title_short Control of aging by the renin–angiotensin system: a review of C. elegans, Drosophila, and mammals
title_sort control of aging by the renin–angiotensin system: a review of c. elegans, drosophila, and mammals
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518657/
https://www.ncbi.nlm.nih.gov/pubmed/36188619
http://dx.doi.org/10.3389/fphar.2022.938650
work_keys_str_mv AT eganbrianm controlofagingbythereninangiotensinsystemareviewofcelegansdrosophilaandmammals
AT scharfandrea controlofagingbythereninangiotensinsystemareviewofcelegansdrosophilaandmammals
AT pohlfranziska controlofagingbythereninangiotensinsystemareviewofcelegansdrosophilaandmammals
AT kornfeldkerry controlofagingbythereninangiotensinsystemareviewofcelegansdrosophilaandmammals